What is NDC 50090-6592?

50090-6592 is the product NDC for Clindamycin Phoaphate Topical USP, 1%, Clindamycin phosphate 10 mg/mL solution, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Clindamycin Phoaphate Topical USP, 1% (Clindamycin Phosphate Topical USP, 1%).

A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Clindamycin Phoaphate Topical USP, 1%?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Clindamycin Phoaphate Topical USP, 1% NDC 50090-6592

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-6592Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-6592Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-6592-0	5009065920050090659200	1 BOTTLE in 1 CARTON (50090-6592-0) / 60 mL in 1 BOTTLEMarketed from Aug 15, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phoaphate Topical USP, 1%
Generic name (nonproprietary): clindamycin phosphate topical usp, 1%
Active ingredients: Clindamycin phosphate — 10 mg/mL
Dosage form: Solution
Route: Topical
Labeler: A-S Medication SolutionsNDC labeler code 50090
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209914
Marketing start: Mar 4, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 50090-6592_a70332eb-6f78-4e96-b489-eb60ad6be2daSPL ID a70332eb-6f78-4e96-b489-eb60ad6be2daSPL set ID 19363055-9ae7-4f0f-979d-93d0ee2c803fRxCUI 309333UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090659200 followed by a unit qualifier and the quantity

Package 50090-6592-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 6, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin phosphate topical solution USP, 1% is indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50090-6592

What is NDC 50090-6592?: 50090-6592 is the product NDC for Clindamycin Phoaphate Topical USP, 1%, Clindamycin phosphate 10 mg/mL solution, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Clindamycin Phoaphate Topical USP, 1% (Clindamycin Phosphate Topical USP, 1%).
What is the active ingredient?: Clindamycin phosphate.
Who is the labeler?: A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Clindamycin Phoaphate Topical USP, 1%?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 209914

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209914
Product	Strength	Form · route	Labeler	Product NDC
Clindamycin Phoaphate Topical Solution USP, 1%clindamycin phosphate topical solution usp, 1%	Clindamycin phosphate 10 mg/mL	SolutionTopical	Encube Ethicals, Inc.	21922-002
Clindamycin Phoaphate Topical Solution USP, 1%clindamycin phosphate topical solution usp, 1%	Clindamycin phosphate 10 mg/mL	SolutionTopical	Northstar Rx LLC	72603-321

Clindamycin Phoaphate Topical USP, 1% (Clindamycin phosphate topical usp, 1%) NDC 50090-6592